The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2
- PMID:35062282
- PMCID: PMC8778387
- DOI: 10.3390/v14010078
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2
Abstract
Coronaviruses (CoVs) constitute a large and diverse subfamily of positive-sense single-stranded RNA viruses. They are found in many mammals and birds and have great importance for the health of humans and farm animals. The current SARS-CoV-2 pandemic, as well as many previous epidemics in humans that were of zoonotic origin, highlights the importance of studying the evolution of the entire CoV subfamily in order to understand how novel strains emerge and which molecular processes affect their adaptation, transmissibility, host/tissue tropism, and patho non-homologous genicity. In this review, we focus on studies over the last two years that reveal the impact of point mutations, insertions/deletions, and intratypic/intertypic homologous and non-homologous recombination events on the evolution of CoVs. We discuss whether the next generations of CoV vaccines should be directed against other CoV proteins in addition to or instead of spike. Based on the observed patterns of molecular evolution for the entire subfamily, we discuss five scenarios for the future evolutionary path of SARS-CoV-2 and the COVID-19 pandemic. Finally, within this evolutionary context, we discuss the recently emerged Omicron (B.1.1.529) VoC.
Keywords: COVID-19; SARS-CoV-2; coronavirus; evolution; pandemic; point mutations; recombination; spike; vaccines.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
- In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.Obajuluwa AO, Okiki PA, Obajuluwa TM, Afolabi OB.Obajuluwa AO, et al.Pan Afr Med J. 2020 Nov 30;37:285. doi: 10.11604/pamj.2020.37.285.24663. eCollection 2020.Pan Afr Med J. 2020.PMID:33654512Free PMC article.
- The Neighborhood of the Spike Gene Is a Hotspot for Modular Intertypic Homologous and Nonhomologous Recombination in Coronavirus Genomes.Nikolaidis M, Markoulatos P, Van de Peer Y, Oliver SG, Amoutzias GD.Nikolaidis M, et al.Mol Biol Evol. 2022 Jan 7;39(1):msab292. doi: 10.1093/molbev/msab292.Mol Biol Evol. 2022.PMID:34638137Free PMC article.
- SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.Kim CH.Kim CH.Int J Mol Sci. 2020 Jun 26;21(12):4549. doi: 10.3390/ijms21124549.Int J Mol Sci. 2020.PMID:32604730Free PMC article.Review.
- Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.Artese A, Svicher V, Costa G, Salpini R, Di Maio VC, Alkhatib M, Ambrosio FA, Santoro MM, Assaraf YG, Alcaro S, Ceccherini-Silberstein F.Artese A, et al.Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.Drug Resist Updat. 2020.PMID:33132205Free PMC article.Review.
- Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.Das JK, Roy S.Das JK, et al.Genomics. 2021 Jul;113(4):2177-2188. doi: 10.1016/j.ygeno.2021.05.008. Epub 2021 May 19.Genomics. 2021.PMID:34019999Free PMC article.
Cited by
- Diversity of gammacoronaviruses and deltacoronaviruses in wild birds and poultry in Russia.Marchenko V, Danilenko A, Kolosova N, Bragina M, Molchanova M, Bulanovich Y, Gorodov V, Leonov S, Gudymo A, Onkhonova G, Svyatchenko S, Ryzhikov A.Marchenko V, et al.Sci Rep. 2022 Nov 12;12(1):19412. doi: 10.1038/s41598-022-23925-z.Sci Rep. 2022.PMID:36371465Free PMC article.
- The enterovirus genome can be translated in an IRES-independent manner that requires the initiation factors eIF2A/eIF2D.Kim H, Aponte-Diaz D, Sotoudegan MS, Shengjuler D, Arnold JJ, Cameron CE.Kim H, et al.PLoS Biol. 2023 Jan 23;21(1):e3001693. doi: 10.1371/journal.pbio.3001693. eCollection 2023 Jan.PLoS Biol. 2023.PMID:36689548Free PMC article.
- Evidence for Recombination as an Evolutionary Mechanism in Coronaviruses: Is SARS-CoV-2 an Exception?Kozlakidis Z.Kozlakidis Z.Front Public Health. 2022 Mar 17;10:859900. doi: 10.3389/fpubh.2022.859900. eCollection 2022.Front Public Health. 2022.PMID:35372203Free PMC article.No abstract available.
- Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela.Jaspe RC, Loureiro CL, Sulbaran Y, Moros ZC, D'Angelo P, Hidalgo M, Rodríguez L, Alarcón V, Aguilar M, Sánchez D, Ramírez J, Garzaro DJ, Zambrano JL, Liprandi F, Rangel HR, Pujol FH.Jaspe RC, et al.Viruses. 2022 Jun 24;14(7):1378. doi: 10.3390/v14071378.Viruses. 2022.PMID:35891359Free PMC article.
- Towards Efficient and Accurate SARS-CoV-2 Genome Sequence Typing Based on Supervised Learning Approaches.Miao M, De Clercq E, Li G.Miao M, et al.Microorganisms. 2022 Sep 4;10(9):1785. doi: 10.3390/microorganisms10091785.Microorganisms. 2022.PMID:36144387Free PMC article.
References
- Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-NCoV and Naming It SARS-CoV-2. Nat. Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous